Summary
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
According to APO Research, The global mRNA Vaccines & Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for mRNA Vaccines & Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for mRNA Vaccines & Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for mRNA Vaccines & Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for mRNA Vaccines & Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of mRNA Vaccines & Therapeutics include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for mRNA Vaccines & Therapeutics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of mRNA Vaccines & Therapeutics, also provides the sales of main regions and countries. Of the upcoming market potential for mRNA Vaccines & Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the mRNA Vaccines & Therapeutics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global mRNA Vaccines & Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for mRNA Vaccines & Therapeutics sales, projected growth trends, production technology, application and end-user industry.
mRNA Vaccines & Therapeutics segment by Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
mRNA Vaccines & Therapeutics segment by Type
Infectious Disease Vaccines
Cancer Vaccines
mRNA Vaccines & Therapeutics segment by Application
Infectious Disease
Cancer
mRNA Vaccines & Therapeutics segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Vaccines & Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of mRNA Vaccines & Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Vaccines & Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of mRNA Vaccines & Therapeutics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Vaccines & Therapeutics sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 mRNA Vaccines & Therapeutics Market by Type
1.2.1 Global mRNA Vaccines & Therapeutics Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 mRNA Vaccines & Therapeutics Market by Application
1.3.1 Global mRNA Vaccines & Therapeutics Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 mRNA Vaccines & Therapeutics Market Dynamics
2.1 mRNA Vaccines & Therapeutics Industry Trends
2.2 mRNA Vaccines & Therapeutics Industry Drivers
2.3 mRNA Vaccines & Therapeutics Industry Opportunities and Challenges
2.4 mRNA Vaccines & Therapeutics Industry Restraints
3 Global Market Growth Prospects
3.1 Global mRNA Vaccines & Therapeutics Revenue Estimates and Forecasts (2019-2030)
3.2 Global mRNA Vaccines & Therapeutics Revenue by Region
3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global mRNA Vaccines & Therapeutics Revenue by Region (2019-2024)
3.2.3 Global mRNA Vaccines & Therapeutics Revenue by Region (2025-2030)
3.2.4 Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2019-2030)
3.3 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts 2019-2030
3.4 Global mRNA Vaccines & Therapeutics Sales by Region
3.4.1 Global mRNA Vaccines & Therapeutics Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global mRNA Vaccines & Therapeutics Sales by Region (2019-2024)
3.4.3 Global mRNA Vaccines & Therapeutics Sales by Region (2025-2030)
3.4.4 Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers
4.1.1 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers (2019-2024)
4.1.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global mRNA Vaccines & Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global mRNA Vaccines & Therapeutics Sales by Manufacturers
4.2.1 Global mRNA Vaccines & Therapeutics Sales by Manufacturers (2019-2024)
4.2.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global mRNA Vaccines & Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global mRNA Vaccines & Therapeutics Sales Price by Manufacturers (2019-2024)
4.4 Global mRNA Vaccines & Therapeutics Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global mRNA Vaccines & Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global mRNA Vaccines & Therapeutics Manufacturers, Product Type & Application
4.7 Global mRNA Vaccines & Therapeutics Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global mRNA Vaccines & Therapeutics Market CR5 and HHI
4.8.2 2023 mRNA Vaccines & Therapeutics Tier 1, Tier 2, and Tier 3
5 mRNA Vaccines & Therapeutics Market by Type
5.1 Global mRNA Vaccines & Therapeutics Revenue by Type
5.1.1 Global mRNA Vaccines & Therapeutics Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global mRNA Vaccines & Therapeutics Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2019-2030)
5.2 Global mRNA Vaccines & Therapeutics Sales by Type
5.2.1 Global mRNA Vaccines & Therapeutics Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global mRNA Vaccines & Therapeutics Sales by Type (2019-2030) & (M Doses)
5.2.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2019-2030)
5.3 Global mRNA Vaccines & Therapeutics Price by Type
6 mRNA Vaccines & Therapeutics Market by Application
6.1 Global mRNA Vaccines & Therapeutics Revenue by Application
6.1.1 Global mRNA Vaccines & Therapeutics Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global mRNA Vaccines & Therapeutics Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2019-2030)
6.2 Global mRNA Vaccines & Therapeutics Sales by Application
6.2.1 Global mRNA Vaccines & Therapeutics Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global mRNA Vaccines & Therapeutics Sales by Application (2019-2030) & (M Doses)
6.2.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2019-2030)
6.3 Global mRNA Vaccines & Therapeutics Price by Application
7 Company Profiles
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics Comapny Information
7.1.2 Moderna Therapeutics Business Overview
7.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
7.1.5 Moderna Therapeutics Recent Developments
7.2 CureVac
7.2.1 CureVac Comapny Information
7.2.2 CureVac Business Overview
7.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 CureVac mRNA Vaccines & Therapeutics Product Portfolio
7.2.5 CureVac Recent Developments
7.3 Translate Bio
7.3.1 Translate Bio Comapny Information
7.3.2 Translate Bio Business Overview
7.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
7.3.5 Translate Bio Recent Developments
7.4 BioNTech
7.4.1 BioNTech Comapny Information
7.4.2 BioNTech Business Overview
7.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 BioNTech mRNA Vaccines & Therapeutics Product Portfolio
7.4.5 BioNTech Recent Developments
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Comapny Information
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
7.5.5 Sangamo Therapeutics Recent Developments
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics Comapny Information
7.6.2 Argos Therapeutics Business Overview
7.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
7.6.5 Argos Therapeutics Recent Developments
7.7 In-Cell-Art
7.7.1 In-Cell-Art Comapny Information
7.7.2 In-Cell-Art Business Overview
7.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
7.7.5 In-Cell-Art Recent Developments
7.8 eTheRNA
7.8.1 eTheRNA Comapny Information
7.8.2 eTheRNA Business Overview
7.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
7.8.5 eTheRNA Recent Developments
7.9 Ethris
7.9.1 Ethris Comapny Information
7.9.2 Ethris Business Overview
7.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Ethris mRNA Vaccines & Therapeutics Product Portfolio
7.9.5 Ethris Recent Developments
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology Comapny Information
7.10.2 Tiba Biotechnology Business Overview
7.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
7.10.5 Tiba Biotechnology Recent Developments
8 North America
8.1 North America mRNA Vaccines & Therapeutics Market Size by Type
8.1.1 North America mRNA Vaccines & Therapeutics Revenue by Type (2019-2030)
8.1.2 North America mRNA Vaccines & Therapeutics Sales by Type (2019-2030)
8.1.3 North America mRNA Vaccines & Therapeutics Price by Type (2019-2030)
8.2 North America mRNA Vaccines & Therapeutics Market Size by Application
8.2.1 North America mRNA Vaccines & Therapeutics Revenue by Application (2019-2030)
8.2.2 North America mRNA Vaccines & Therapeutics Sales by Application (2019-2030)
8.2.3 North America mRNA Vaccines & Therapeutics Price by Application (2019-2030)
8.3 North America mRNA Vaccines & Therapeutics Market Size by Country
8.3.1 North America mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America mRNA Vaccines & Therapeutics Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America mRNA Vaccines & Therapeutics Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe mRNA Vaccines & Therapeutics Market Size by Type
9.1.1 Europe mRNA Vaccines & Therapeutics Revenue by Type (2019-2030)
9.1.2 Europe mRNA Vaccines & Therapeutics Sales by Type (2019-2030)
9.1.3 Europe mRNA Vaccines & Therapeutics Price by Type (2019-2030)
9.2 Europe mRNA Vaccines & Therapeutics Market Size by Application
9.2.1 Europe mRNA Vaccines & Therapeutics Revenue by Application (2019-2030)
9.2.2 Europe mRNA Vaccines & Therapeutics Sales by Application (2019-2030)
9.2.3 Europe mRNA Vaccines & Therapeutics Price by Application (2019-2030)
9.3 Europe mRNA Vaccines & Therapeutics Market Size by Country
9.3.1 Europe mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe mRNA Vaccines & Therapeutics Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe mRNA Vaccines & Therapeutics Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China mRNA Vaccines & Therapeutics Market Size by Type
10.1.1 China mRNA Vaccines & Therapeutics Revenue by Type (2019-2030)
10.1.2 China mRNA Vaccines & Therapeutics Sales by Type (2019-2030)
10.1.3 China mRNA Vaccines & Therapeutics Price by Type (2019-2030)
10.2 China mRNA Vaccines & Therapeutics Market Size by Application
10.2.1 China mRNA Vaccines & Therapeutics Revenue by Application (2019-2030)
10.2.2 China mRNA Vaccines & Therapeutics Sales by Application (2019-2030)
10.2.3 China mRNA Vaccines & Therapeutics Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia mRNA Vaccines & Therapeutics Market Size by Type
11.1.1 Asia mRNA Vaccines & Therapeutics Revenue by Type (2019-2030)
11.1.2 Asia mRNA Vaccines & Therapeutics Sales by Type (2019-2030)
11.1.3 Asia mRNA Vaccines & Therapeutics Price by Type (2019-2030)
11.2 Asia mRNA Vaccines & Therapeutics Market Size by Application
11.2.1 Asia mRNA Vaccines & Therapeutics Revenue by Application (2019-2030)
11.2.2 Asia mRNA Vaccines & Therapeutics Sales by Application (2019-2030)
11.2.3 Asia mRNA Vaccines & Therapeutics Price by Application (2019-2030)
11.3 Asia mRNA Vaccines & Therapeutics Market Size by Country
11.3.1 Asia mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia mRNA Vaccines & Therapeutics Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia mRNA Vaccines & Therapeutics Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA mRNA Vaccines & Therapeutics Market Size by Type
12.1.1 MEALA mRNA Vaccines & Therapeutics Revenue by Type (2019-2030)
12.1.2 MEALA mRNA Vaccines & Therapeutics Sales by Type (2019-2030)
12.1.3 MEALA mRNA Vaccines & Therapeutics Price by Type (2019-2030)
12.2 MEALA mRNA Vaccines & Therapeutics Market Size by Application
12.2.1 MEALA mRNA Vaccines & Therapeutics Revenue by Application (2019-2030)
12.2.2 MEALA mRNA Vaccines & Therapeutics Sales by Application (2019-2030)
12.2.3 MEALA mRNA Vaccines & Therapeutics Price by Application (2019-2030)
12.3 MEALA mRNA Vaccines & Therapeutics Market Size by Country
12.3.1 MEALA mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA mRNA Vaccines & Therapeutics Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA mRNA Vaccines & Therapeutics Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 mRNA Vaccines & Therapeutics Value Chain Analysis
13.1.1 mRNA Vaccines & Therapeutics Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 mRNA Vaccines & Therapeutics Production Mode & Process
13.2 mRNA Vaccines & Therapeutics Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 mRNA Vaccines & Therapeutics Distributors
13.2.3 mRNA Vaccines & Therapeutics Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Infectious Disease Vaccines Major Manufacturers
Table 3. Cancer Vaccines Major Manufacturers
Table 4. Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Infectious Disease Major Manufacturers
Table 6. Cancer Major Manufacturers
Table 7. mRNA Vaccines & Therapeutics Industry Trends
Table 8. mRNA Vaccines & Therapeutics Industry Drivers
Table 9. mRNA Vaccines & Therapeutics Industry Opportunities and Challenges
Table 10. mRNA Vaccines & Therapeutics Industry Restraints
Table 11. Global mRNA Vaccines & Therapeutics Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global mRNA Vaccines & Therapeutics Revenue by Region (2019-2024) & (US$ Million)
Table 13. Global mRNA Vaccines & Therapeutics Revenue by Region (2025-2030) & (US$ Million)
Table 14. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2019-2024)
Table 15. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2025-2030)
Table 16. Global mRNA Vaccines & Therapeutics Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 17. Global mRNA Vaccines & Therapeutics Sales by Region (2019-2024) & (M Doses)
Table 18. Global mRNA Vaccines & Therapeutics Sales by Region (2025-2030) & (M Doses)
Table 19. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2019-2024)
Table 20. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2025-2030)
Table 21. Global mRNA Vaccines & Therapeutics Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 22. Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturers (2019-2024)
Table 23. Global mRNA Vaccines & Therapeutics Sales by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 25. Global mRNA Vaccines & Therapeutics Sales Price (USD/Doses) of Manufacturers (2019-2024)
Table 26. Global mRNA Vaccines & Therapeutics Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 27. Global mRNA Vaccines & Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
Table 28. Global mRNA Vaccines & Therapeutics Manufacturers, Product Type & Application
Table 29. Global mRNA Vaccines & Therapeutics Manufacturers Commercialization Time
Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global mRNA Vaccines & Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 32. Global mRNA Vaccines & Therapeutics Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global mRNA Vaccines & Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global mRNA Vaccines & Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2019-2024)
Table 36. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2025-2030)
Table 37. Global mRNA Vaccines & Therapeutics Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 38. Global mRNA Vaccines & Therapeutics Sales by Type (2019-2024) & (M Doses)
Table 39. Global mRNA Vaccines & Therapeutics Sales by Type (2025-2030) & (M Doses)
Table 40. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2019-2024)
Table 41. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2025-2030)
Table 42. Global mRNA Vaccines & Therapeutics Price by Type (2019-2024) & (USD/Doses)
Table 43. Global mRNA Vaccines & Therapeutics Price by Type (2025-2030) & (USD/Doses)
Table 44. Global mRNA Vaccines & Therapeutics Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 45. Global mRNA Vaccines & Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global mRNA Vaccines & Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2019-2024)
Table 48. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2025-2030)
Table 49. Global mRNA Vaccines & Therapeutics Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 50. Global mRNA Vaccines & Therapeutics Sales by Application (2019-2024) & (M Doses)
Table 51. Global mRNA Vaccines & Therapeutics Sales by Application (2025-2030) & (M Doses)
Table 52. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2019-2024)
Table 53. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2025-2030)
Table 54. Global mRNA Vaccines & Therapeutics Price by Application (2019-2024) & (USD/Doses)
Table 55. Global mRNA Vaccines & Therapeutics Price by Application (2025-2030) & (USD/Doses)
Table 56. Moderna Therapeutics Company Information
Table 57. Moderna Therapeutics Business Overview
Table 58. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 59. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
Table 60. Moderna Therapeutics Recent Development
Table 61. CureVac Company Information
Table 62. CureVac Business Overview
Table 63. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 64. CureVac mRNA Vaccines & Therapeutics Product Portfolio
Table 65. CureVac Recent Development
Table 66. Translate Bio Company Information
Table 67. Translate Bio Business Overview
Table 68. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 69. Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
Table 70. Translate Bio Recent Development
Table 71. BioNTech Company Information
Table 72. BioNTech Business Overview
Table 73. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 74. BioNTech mRNA Vaccines & Therapeutics Product Portfolio
Table 75. BioNTech Recent Development
Table 76. Sangamo Therapeutics Company Information
Table 77. Sangamo Therapeutics Business Overview
Table 78. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 79. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
Table 80. Sangamo Therapeutics Recent Development
Table 81. Argos Therapeutics Company Information
Table 82. Argos Therapeutics Business Overview
Table 83. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 84. Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
Table 85. Argos Therapeutics Recent Development
Table 86. In-Cell-Art Company Information
Table 87. In-Cell-Art Business Overview
Table 88. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 89. In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
Table 90. In-Cell-Art Recent Development
Table 91. eTheRNA Company Information
Table 92. eTheRNA Business Overview
Table 93. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 94. eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
Table 95. eTheRNA Recent Development
Table 96. Ethris Company Information
Table 97. Ethris Business Overview
Table 98. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 99. Ethris mRNA Vaccines & Therapeutics Product Portfolio
Table 100. Ethris Recent Development
Table 101. Tiba Biotechnology Company Information
Table 102. Tiba Biotechnology Business Overview
Table 103. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 104. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
Table 105. Tiba Biotechnology Recent Development
Table 106. North America mRNA Vaccines & Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 107. North America mRNA Vaccines & Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 108. North America mRNA Vaccines & Therapeutics Sales by Type (2019-2024) & (M Doses)
Table 109. North America mRNA Vaccines & Therapeutics Sales by Type (2025-2030) & (M Doses)
Table 110. North America mRNA Vaccines & Therapeutics Sales Price by Type (2019-2024) & (USD/Doses)
Table 111. North America mRNA Vaccines & Therapeutics Sales Price by Type (2025-2030) & (USD/Doses)
Table 112. North America mRNA Vaccines & Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 113. North America mRNA Vaccines & Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 114. North America mRNA Vaccines & Therapeutics Sales by Application (2019-2024) & (M Doses)
Table 115. North America mRNA Vaccines & Therapeutics Sales by Application (2025-2030) & (M Doses)
Table 116. North America mRNA Vaccines & Therapeutics Sales Price by Application (2019-2024) & (USD/Doses)
Table 117. North America mRNA Vaccines & Therapeutics Sales Price by Application (2025-2030) & (USD/Doses)
Table 118. North America mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 119. North America mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 120. North America mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 121. North America mRNA Vaccines & Therapeutics Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 122. North America mRNA Vaccines & Therapeutics Sales by Country (2019-2024) & (M Doses)
Table 123. North America mRNA Vaccines & Therapeutics Sales by Country (2025-2030) & (M Doses)
Table 124. North America mRNA Vaccines & Therapeutics Sales Price by Country (2019-2024) & (USD/Doses)
Table 125. North America mRNA Vaccines & Therapeutics Sales Price by Country (2025-2030) & (USD/Doses)
Table 126. US mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 127. Canada mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 128. Europe mRNA Vaccines & Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 129. Europe mRNA Vaccines & Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 130. Europe mRNA Vaccines & Therapeutics Sales by Type (2019-2024) & (M Doses)
Table 131. Europe mRNA Vaccines & Therapeutics Sales by Type (2025-2030) & (M Doses)
Table 132. Europe mRNA Vaccines & Therapeutics Sales Price by Type (2019-2024) & (USD/Doses)
Table 133. Europe mRNA Vaccines & Therapeutics Sales Price by Type (2025-2030) & (USD/Doses)
Table 134. Europe mRNA Vaccines & Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 135. Europe mRNA Vaccines & Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 136. Europe mRNA Vaccines & Therapeutics Sales by Application (2019-2024) & (M Doses)
Table 137. Europe mRNA Vaccines & Therapeutics Sales by Application (2025-2030) & (M Doses)
Table 138. Europe mRNA Vaccines & Therapeutics Sales Price by Application (2019-2024) & (USD/Doses)
Table 139. Europe mRNA Vaccines & Therapeutics Sales Price by Application (2025-2030) & (USD/Doses)
Table 140. Europe mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 141. Europe mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 142. Europe mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 143. Europe mRNA Vaccines & Therapeutics Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 144. Europe mRNA Vaccines & Therapeutics Sales by Country (2019-2024) & (M Doses)
Table 145. Europe mRNA Vaccines & Therapeutics Sales by Country (2025-2030) & (M Doses)
Table 146. Europe mRNA Vaccines & Therapeutics Sales Price by Country (2019-2024) & (USD/Doses)
Table 147. Europe mRNA Vaccines & Therapeutics Sales Price by Country (2025-2030) & (USD/Doses)
Table 148. Germany mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 149. France mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 150. mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 151. mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 152. mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 153. China mRNA Vaccines & Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 154. China mRNA Vaccines & Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 155. China mRNA Vaccines & Therapeutics Sales by Type (2019-2024) & (M Doses)
Table 156. China mRNA Vaccines & Therapeutics Sales by Type (2025-2030) & (M Doses)
Table 157. China mRNA Vaccines & Therapeutics Sales Price by Type (2019-2024) & (USD/Doses)
Table 158. China mRNA Vaccines & Therapeutics Sales Price by Type (2025-2030) & (USD/Doses)
Table 159. China mRNA Vaccines & Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 160. China mRNA Vaccines & Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 161. China mRNA Vaccines & Therapeutics Sales by Application (2019-2024) & (M Doses)
Table 162. China mRNA Vaccines & Therapeutics Sales by Application (2025-2030) & (M Doses)
Table 163. China mRNA Vaccines & Therapeutics Sales Price by Application (2019-2024) & (USD/Doses)
Table 164. China mRNA Vaccines & Therapeutics Sales Price by Application (2025-2030) & (USD/Doses)
Table 165. Asia mRNA Vaccines & Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 166. Asia mRNA Vaccines & Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 167. Asia mRNA Vaccines & Therapeutics Sales by Type (2019-2024) & (M Doses)
Table 168. Asia mRNA Vaccines & Therapeutics Sales by Type (2025-2030) & (M Doses)
Table 169. Asia mRNA Vaccines & Therapeutics Sales Price by Type (2019-2024) & (USD/Doses)
Table 170. Asia mRNA Vaccines & Therapeutics Sales Price by Type (2025-2030) & (USD/Doses)
Table 171. Asia mRNA Vaccines & Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 172. Asia mRNA Vaccines & Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 173. Asia mRNA Vaccines & Therapeutics Sales by Application (2019-2024) & (M Doses)
Table 174. Asia mRNA Vaccines & Therapeutics Sales by Application (2025-2030) & (M Doses)
Table 175. Asia mRNA Vaccines & Therapeutics Sales Price by Application (2019-2024) & (USD/Doses)
Table 176. Asia mRNA Vaccines & Therapeutics Sales Price by Application (2025-2030) & (USD/Doses)
Table 177. Asia mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 178. Asia mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 179. Asia mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 180. Asia mRNA Vaccines & Therapeutics Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 181. Asia mRNA Vaccines & Therapeutics Sales by Country (2019-2024) & (M Doses)
Table 182. Asia mRNA Vaccines & Therapeutics Sales by Country (2025-2030) & (M Doses)
Table 183. Asia mRNA Vaccines & Therapeutics Sales Price by Country (2019-2024) & (USD/Doses)
Table 184. Asia mRNA Vaccines & Therapeutics Sales Price by Country (2025-2030) & (USD/Doses)
Table 185. Japan mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 186. South Korea mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 187. mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 188. mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 189. mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 190. mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 191. mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 192. mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 193. MEALA mRNA Vaccines & Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 194. MEALA mRNA Vaccines & Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 195. MEALA mRNA Vaccines & Therapeutics Sales by Type (2019-2024) & (M Doses)
Table 196. MEALA mRNA Vaccines & Therapeutics Sales by Type (2025-2030) & (M Doses)
Table 197. MEALA mRNA Vaccines & Therapeutics Sales Price by Type (2019-2024) & (USD/Doses)
Table 198. MEALA mRNA Vaccines & Therapeutics Sales Price by Type (2025-2030) & (USD/Doses)
Table 199. MEALA mRNA Vaccines & Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 200. MEALA mRNA Vaccines & Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 201. MEALA mRNA Vaccines & Therapeutics Sales by Application (2019-2024) & (M Doses)
Table 202. MEALA mRNA Vaccines & Therapeutics Sales by Application (2025-2030) & (M Doses)
Table 203. MEALA mRNA Vaccines & Therapeutics Sales Price by Application (2019-2024) & (USD/Doses)
Table 204. MEALA mRNA Vaccines & Therapeutics Sales Price by Application (2025-2030) & (USD/Doses)
Table 205. MEALA mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 206. MEALA mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 207. MEALA mRNA Vaccines & Therapeutics Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 208. MEALA mRNA Vaccines & Therapeutics Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 209. MEALA mRNA Vaccines & Therapeutics Sales by Country (2019-2024) & (M Doses)
Table 210. MEALA mRNA Vaccines & Therapeutics Sales by Country (2025-2030) & (M Doses)
Table 211. MEALA mRNA Vaccines & Therapeutics Sales Price by Country (2019-2024) & (USD/Doses)
Table 212. MEALA mRNA Vaccines & Therapeutics Sales Price by Country (2025-2030) & (USD/Doses)
Table 213. Mexico mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 214. Brazil mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 215. Israel mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 216. Argentina mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 217. Colombia mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 218. Turkey mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 219. Saudi Arabia mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 220. UAE mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Table 221. Key Raw Materials
Table 222. Raw Materials Key Suppliers
Table 223. mRNA Vaccines & Therapeutics Distributors List
Table 224. mRNA Vaccines & Therapeutics Customers List
Table 225. Research Programs/Design for This Report
Table 226. Authors List of This Report
Table 227. Secondary Sources
Table 228. Primary Sources
List of Figures
Figure 1. mRNA Vaccines & Therapeutics Product Picture
Figure 2. Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global mRNA Vaccines & Therapeutics Market Size Share 2019 VS 2023 VS 2030
Figure 4. Infectious Disease Vaccines Picture
Figure 5. Cancer Vaccines Picture
Figure 6. Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global mRNA Vaccines & Therapeutics Market Size Share 2019 VS 2023 VS 2030
Figure 8. Infectious Disease Picture
Figure 9. Cancer Picture
Figure 10. Global mRNA Vaccines & Therapeutics Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global mRNA Vaccines & Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 12. Global mRNA Vaccines & Therapeutics Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 13. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 2023 Versus 2030
Figure 14. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2019-2030)
Figure 15. Global mRNA Vaccines & Therapeutics Sales (2019-2030) & (M Doses)
Figure 16. Global mRNA Vaccines & Therapeutics Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 17. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2019-2030)
Figure 18. US & Canada mRNA Vaccines & Therapeutics Sales YoY (2019-2030) & (M Doses)
Figure 19. Europe mRNA Vaccines & Therapeutics Sales YoY (2019-2030) & (M Doses)
Figure 20. China mRNA Vaccines & Therapeutics Sales YoY (2019-2030) & (M Doses)
Figure 21. Asia (Excluding China) mRNA Vaccines & Therapeutics Sales YoY (2019-2030) & (M Doses)
Figure 22. Middle East, Africa and Latin America (Excluding China) mRNA Vaccines & Therapeutics Sales YoY (2019-2030) & (M Doses)
Figure 23. Global mRNA Vaccines & Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 24. Global mRNA Vaccines & Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global mRNA Vaccines & Therapeutics Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 28. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2019-2030)
Figure 29. Global mRNA Vaccines & Therapeutics Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 30. Global mRNA Vaccines & Therapeutics Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 31. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2019-2030)
Figure 32. Global mRNA Vaccines & Therapeutics Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 33. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 34. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2019-2030)
Figure 35. Global mRNA Vaccines & Therapeutics Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 36. Global mRNA Vaccines & Therapeutics Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 37. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2019-2030)
Figure 38. North America mRNA Vaccines & Therapeutics Revenue Share by Type (2019-2030)
Figure 39. North America mRNA Vaccines & Therapeutics Sales Share by Type (2019-2030)
Figure 40. North America mRNA Vaccines & Therapeutics Revenue Share by Application (2019-2030)
Figure 41. North America mRNA Vaccines & Therapeutics Sales Share by Application (2019-2030)
Figure 42. North America mRNA Vaccines & Therapeutics Revenue Share by Country (2019-2030)
Figure 43. North America mRNA Vaccines & Therapeutics Sales Share by Country (2019-2030)
Figure 44. Europe mRNA Vaccines & Therapeutics Revenue Share by Type (2019-2030)
Figure 45. Europe mRNA Vaccines & Therapeutics Sales Share by Type (2019-2030)
Figure 46. Europe mRNA Vaccines & Therapeutics Revenue Share by Application (2019-2030)
Figure 47. Europe mRNA Vaccines & Therapeutics Sales Share by Application (2019-2030)
Figure 48. Europe mRNA Vaccines & Therapeutics Revenue Share by Country (2019-2030)
Figure 49. Europe mRNA Vaccines & Therapeutics Sales Share by Country (2019-2030)
Figure 50. China mRNA Vaccines & Therapeutics Revenue Share by Type (2019-2030)
Figure 51. China mRNA Vaccines & Therapeutics Sales Share by Type (2019-2030)
Figure 52. China mRNA Vaccines & Therapeutics Revenue Share by Application (2019-2030)
Figure 53. China mRNA Vaccines & Therapeutics Sales Share by Application (2019-2030)
Figure 54. Asia mRNA Vaccines & Therapeutics Revenue Share by Type (2019-2030)
Figure 55. Asia mRNA Vaccines & Therapeutics Sales Share by Type (2019-2030)
Figure 56. Asia mRNA Vaccines & Therapeutics Revenue Share by Application (2019-2030)
Figure 57. Asia mRNA Vaccines & Therapeutics Sales Share by Application (2019-2030)
Figure 58. Asia mRNA Vaccines & Therapeutics Revenue Share by Country (2019-2030)
Figure 59. Asia mRNA Vaccines & Therapeutics Sales Share by Country (2019-2030)
Figure 60. MEALA mRNA Vaccines & Therapeutics Revenue Share by Type (2019-2030)
Figure 61. MEALA mRNA Vaccines & Therapeutics Sales Share by Type (2019-2030)
Figure 62. MEALA mRNA Vaccines & Therapeutics Revenue Share by Application (2019-2030)
Figure 63. MEALA mRNA Vaccines & Therapeutics Sales Share by Application (2019-2030)
Figure 64. MEALA mRNA Vaccines & Therapeutics Revenue Share by Country (2019-2030)
Figure 65. MEALA mRNA Vaccines & Therapeutics Sales Share by Country (2019-2030)
Figure 66. mRNA Vaccines & Therapeutics Value Chain
Figure 67. Manufacturing Cost Structure
Figure 68. mRNA Vaccines & Therapeutics Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Years Considered
Figure 72. Research Process
Figure 73. Key Executives Interviewed
